Education
About Us
Working with TipRanks
Follow Us
Perrigo Company (PRGO)
:PRGO
PRGO Stock Chart & Stats
$21.62
-$0.12(-0.48%)
At close: 4:00 PM EST
$21.62
-$0.12(-0.48%)
Day’s Range― - ―
52-Week Range$15.05 - $30.93
Previous CloseN/A
Volume301.70K
Average Volume (3M)1.94M
Market Cap
$2.78B
Enterprise ValueN/A
Total Cash (Recent Filing)$432.10M
Total Debt (Recent Filing)$36.60M
Price to Earnings (P/E)―
Beta0.24
Next Earnings
Feb 26, 2026EPS Estimate
0.81Last Dividend Ex-Date
Aug 29, 2025Dividend Yield5.55%
Share Statistics
EPS (TTM)0.80
Shares Outstanding137,582,810
10 Day Avg. Volume2,294,497
30 Day Avg. Volume1,941,999
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.82
Price to Sales (P/S)0.81
P/FCF Ratio14.44
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$27.50Price Target Upside27.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Asset DivestmentPRGO could unlock cash by selling the infant formula business that is seeing sell-outs stabilize and focus on investing elsewhere, and more cash could be unlocked with the Oral Care business.
Consumer BehaviorPerrigo is expected to benefit from consumers trading down in frequently used categories like soaps, shampoos, and analgesics.
Strategic InitiativesManagement is still progressing on its 'Three S' plan (stabilize, streamline, strengthen) including winning unit share in OTC and net contract wins.
Bears Say
Infant Formula BusinessRecent wins have been overshadowed by a slower than expected recovery in the infant formula business.
Overall Business PerformanceSales were down -0.9% YOY, lower than the analyst's estimate, impacted by divestitures and exited products.
Sales PerformanceSales were impacted by a -4.4% decline in organic sales, -1.3% decline from divestitures and exited products, and +1.6% benefit from FX.
Perrigo Company News
PRGO FAQ
What was Perrigo Company’s price range in the past 12 months?
Perrigo Company lowest stock price was $15.05 and its highest was $30.93 in the past 12 months.
What is Perrigo Company’s market cap?
Perrigo Company’s market cap is $2.78B.
When is Perrigo Company’s upcoming earnings report date?
Perrigo Company’s upcoming earnings report date is Feb 26, 2026 which is in 110 days.
How were Perrigo Company’s earnings last quarter?
Perrigo Company released its earnings results on Nov 05, 2025. The company reported $0.8 earnings per share for the quarter, beating the consensus estimate of $0.755 by $0.045.
Is Perrigo Company overvalued?
According to Wall Street analysts Perrigo Company’s price is currently Undervalued.
Does Perrigo Company pay dividends?
Perrigo Company pays a Quarterly dividend of $0.29 which represents an annual dividend yield of 5.55%. See more information on Perrigo Company dividends here
What is Perrigo Company’s EPS estimate?
Perrigo Company’s EPS estimate is 0.81.
How many shares outstanding does Perrigo Company have?
Perrigo Company has 137,582,810 shares outstanding.
What happened to Perrigo Company’s price movement after its last earnings report?
Perrigo Company reported an EPS of $0.8 in its last earnings report, beating expectations of $0.755. Following the earnings report the stock price went down -25.211%.
Which hedge fund is a major shareholder of Perrigo Company?
Currently, no hedge funds are holding shares in PRGO
Perrigo Company Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.50 (27.20% Upside)
$27.50 (27.20% Upside)
Blogger Sentiment
Bullish
PRGO Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 77.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $355.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 19.1%
Last 30 Days ▲ 26.9%
Last 30 Days ▲ 26.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.82%
12-Months-Change
Fundamentals
Return on Equity
-0.65%
Trailing 12-Months
Asset Growth
-2.92%
Trailing 12-Months
Company Description
Perrigo Company
Perrigo Company plc is a global healthcare supplier that focuses on providing quality, affordable self-care products. Founded in 1887 and headquartered in Dublin, Ireland, Perrigo operates primarily in the over-the-counter (OTC) pharmaceutical and consumer healthcare sectors. The company specializes in developing, manufacturing, and distributing a broad range of products including non-prescription medications, vitamins, dietary supplements, and personal care items. Its mission is to empower consumers to take charge of their health by providing them with affordable, accessible healthcare solutions.
PRGO Company Deck
PRGO Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Perrigo demonstrated strong share gains and operational efficiencies in a challenging market, with notable achievements in U.S. OTC and European brand performance. However, the decline in organic net sales, particularly in the OTC and Infant Formula segments, along with soft market conditions, offset some of these gains. The company remains focused on strategic reviews and cost management to navigate these challenges.View all PRGO earnings summariesPRGO Stock 12 Month Forecast
Average Price Target
$27.50
▲(27.20% Upside)
Technical Analysis
Viatris
―
Supernus Pharmaceuticals
―
Teva Pharmaceutical
―
Indivior
―
Amneal Pharmaceuticals
―
Ownership Overview
0.33% Insiders
32.13% Mutual Funds
3.95% Other Institutional Investors
34.89% Public Companies and
Individual Investors